相关实验视频

Updated: Jul 10, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

老年患者的心脏再同步治疗的好处:患者一级的元分析

Emily P Zeitler¹, Frederik Dalgaard², William T Abraham³

¹Dartmouth Health and The Dartmouth Institute, Lebanon, NH.

American heart journal

|November 20, 2023

概括

心脏再同步治疗 (CRT) 有效地减少心力衰竭住院和死亡率. 老年患者 (≥70岁) 从CRT中受益同样多或更多,这表明年龄不应限制治疗.

科学领域:

心脏病学心脏病学
老年医学老年医学
临床试验临床试验

背景情况:

心脏再同步治疗 (CRT) 改善了心力衰竭 (HF) 患者的结果.
患有高血压的老年人 (≥70岁) 在临床试验中通常代表性不足.
在老年高压患者中研究CRT的疗效至关重要.

结论:

在适当指示的老年患者中,CRT的益处与适当指示的老年患者相似或更大.
年龄不应该成为考虑CRT的障碍.
对于心力衰竭的老年患者来说,CRT是一种有价值的治疗方法.

更多相关视频

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...